Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance

Experimental Eye Research

Volumn 116, Issue , 2013, Pages 190-198

  Dennison, Jessica L ^a   Stack, Jim ^a   Beatty, Stephen ^a,b   Nolan, John M ^a,b  

^a South East Technological University   (Ireland)

^b Institute of Vision Research   (Ireland)

Author keywords

Customized heterochromatic flicker photometry; Fundus autofluorescence; Fundus reflectance; Macular pigment

Indexed keywords

MACULAR PIGMENT; UNCLASSIFIED DRUG; VISUAL PIGMENT;

ACCURACY; ADULT; ARTICLE; AUTOFLUORESCENCE; COMPARATIVE STUDY; CUSTOMIZED HETEROCHROMATIC FLICKER PHOTOMETRY; DENSITOMETER; DUAL WAVELENGTH FUNDUS AUTOFLUORESCENCE; EYE EXAMINATION; FEMALE; FUNDUS CAMERA; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PHOTOMETRY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFLECTOMETRY; SINGLE WAVELENGTH FUNDUS REFLECTANCE; VISUAL ACUITY;

CUSTOMIZED HETEROCHROMATIC FLICKER PHOTOMETRY; FUNDUS AUTOFLUORESCENCE; FUNDUS REFLECTANCE; MACULAR PIGMENT;

DENSITOMETRY; HUMANS; LUTEIN; MACULA LUTEA; MIDDLE AGED; PHOTOMETRY; RETINAL PIGMENTS; SPECTROMETRY, FLUORESCENCE; XANTHOPHYLLS;

EID: 84884952184     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.08.014     Document Type: Article

References (84)

1. Beatty S., Murray I.J., Henson D.B., Carden D., Koh H.H., Boulton M.E. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest. Ophthalmol. Vis. Sci. 2001, 42:439-446.
2. Berendschot T.T.J.M., van Norren D. Objective determination of the macular pigment optical density using fundus reflectance spectroscopy. Arch. Biochem. Biophys. 2004, 430:149-155.
3. Berendschot T.T.J.M., van Norren D. On the age dependency of the macular pigment optical density. Exp. Eye Res. 2005, 81:602-609.
4. Berendschot T.T.J.M., van Norren D. Macular pigment shows ringlike structures. Invest. Ophthalmol. Vis. Sci. 2006, 47:709-714.
5. Bernstein P.S., Gellermann W. Author response: assessment of the Raman method of measuring human macular pigment (II). Invest. Ophthalmol. Vis. Sci. 2003, [serial online], published Dec. 30, 2003.
6. Bernstein P.S., Yoshida M.D., Katz N.B., McClane R.W., Gellermann W. Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol. Vis. Sci. 1998, 39:2003-2011.
7. Bernstein P.S., Zhao D.Y., Wintch S.W., Ermakov I.V., McClane R.W., Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 2002, 109:1780-1787.
8. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
9. Bone R.A., Landrum J.T., Guerra L.H., Ruiz C.A. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J.Nutr. 2003, 133:992-998.
10. Bone R.A., Landrum J.T. Heterochromatic flicker photometry. Arch. Biochem. Biophys. 2004, 430:137-142.
11. Bone R.A., Landrum J.T. Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters. Arch. Biochem. Biophys. 2010, 504:50-55.
12. Bone R.A., Landrum J.T., Cains A. Optical-density spectra of the macular pigment invivo and invitro. Vis. Res. 1992, 32:105-110.
13. Bone R.A., Landrum J.T., Cao Y., Howard A.N., varez-Calderon F. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr. Metab. (Lond) 2007, 4(12):12.
14. Bressler N.M. Age-related macular degeneration is the leading cause of blindness. JAMA 2004, 291:1900-1901.
15. Brindley G.S., Willmer E.N. The reflexion of light from the macular and peripheral fundus oculi in man. J.Physiol. 1952, 116:350-356.
16. Canovas R., Lima V.C., Garcia P., Morini C., Prata T.S., Rosen R.B. Comparison between macular pigment optical density measurements using two-wavelength autofluorescence and heterochromatic flicker photometry techniques. Invest Ophthalmol. Vis. Sci. 2010, 51:3152-3156.
17. Chen S.F., Chang Y., Wu J.C. The spatial distribution of macular pigment in humans. Curr. Eye Res. 2001, 23:422-434.
18. Connolly E.E., Beatty S., Loughman J., Howard A.N., Louw M.S., Nolan J.M. Supplementation with all three macular carotenoids: response, stability, and safety. Invest Ophthalmol. Vis. Sci. 2011, 52:9207-9217.
19. Davies N.P., Morland A.B. Color matching in diabetes: optical density of the crystalline lens and macular pigments. Invest Ophthalmol. Vis. Sci. 2002, 43:281-289.
20. Delori F., Greenberg J.P., Woods R.L., Fischer J., Duncker T., Sparrow J., Smith R.T. Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope. Invest Ophthalmol. Vis. Sci. 2011, 52:9379-9390.
21. Delori F.C. Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch. Biochem. Biophys. 2004, 430:156-162.
22. Delori F.C., Goger D.G., Hammond B.R., Snodderly D.M., Burns S.A. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J.Opt. Soc. Am. A Opt. Image Sci. Vis. 2001, 18:1212-1230.
23. Delori F.C., Goger D.G., Keilhauer C., Salvetti P., Staurenghi G. Bimodal spatial distribution of macular pigment: evidence of a gender relationship. J.Opt. Soc. Am. A Opt. Image Sci. Vis. 2006, 23:521-538.
24. Gaillard E.R., Zheng L., Merriam J.C., Dillon J. Age-related changes in the absorption characteristics of the primate lens. Invest Ophthalmol. Vis. Sci. 2000, 41:1454-1459.
25. Gale C.R., Hall N.F., Phillips D.I.W., Martyn C.N. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2003, 44:2461-2465.
26. Garcia-Layana A., Recalde S., Alaman A.S., Robredo P.F. Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial. Nutrients 2013, 5:543-551.
27. Gellermann W., Bernstein P.S. Assessment of the validity of invivo methods of measuring human macular pigment optical density. Optom. Vis. Sci. 2006, 83:254-255.
28. Hammond B.R., Fletcher L.M. Influence of the dietary carotenoids lutein and zeaxanthin on visual performance: application to baseball. Am. J. Clin. Nutr. 2012, 96:1207S-1213S.
29. Hammond B.R., Fletcher L.M., Elliott J.G. Glare disability, photostress recovery, and chromatic contrast: relation to macular pigment and serum lutein and zeaxanthin. Invest Ophthalmol. Vis. Sci. 2013, 54:476-481.
30. Hammond B.R., Johnson E.J., Russell R.M., Krinsky N.I., Yeum K.J., Edwards R.B., Snodderly D.M. Dietary modification of human macular pigment density. Invest. Ophthalmol. Vis. Sci. 1997, 38:1795-1801.
31. Hammond B.R., Wooten B.R. Comments on the use of Raman spectroscopy for the invivo measurement of human macular pigment. Appl. Spectrosc. 2006, 60:1348-1349.
32. Hammond B.R., Wooten B.R., Smollon B. Assessment of the validity of invivo methods of measuring human macular pigment optical density. Optom. Vis. Sci. 2005, 82:387-404.
33. Hammond B.R., Wooten B.R., Snodderly D.M. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vis. Res. 1996, 36:3003-3009.
34. Hirsch J., Curcio C.A. The spatial resolution capacity of human foveal retina. Vis. Res. 1989, 29:1095-1101.
35. Howells O., Eperjesi F., Bartlett H. Measuring macular pigment optical density invivo: a review of techniques. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249:315-347.
36. Huang Y.M., Yan S.F., Ma L., Zou Z.Y., Xu X.R., Dou H.L., Lin X.M. Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration. Nutrition 2013, 29:387-392.
37. Kilbride P.E., Alexander K.R., Fishman M., Fishman G.A. Human macular pigment assessed by imaging fundus reflectometry. Vis. Res. 1989, 29:663-674.
38. Kirby M.L., Beatty S., Loane E., Akkali M., Connolly E.E., Stack J., Nolan J.M. Acentral dip in the macular pigment spatial profile is associated with age and smoking. Invest Ophthalmol. Vis. Sci. 2010, 50(12):6722-6728.
39. Kirby M.L., Galea M., Loane E., Stack J., Beatty S., Nolan J.M. Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest Ophthalmol. Vis. Sci. 2009, 50:1383-1391.
40. Koh H.H., Murray I.J., Nolan D., Carden D., Feather J. Serum and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp. Eye Res. 2004, 79:21-27.
41. Landrum J., Bone R., Mendez V., Valenciaga A., Babino D. Comparison of dietary supplementation with lutein diacetate and lutein: a pilot study of the effects on serum and macular pigment. Acta Biochim. Pol. 2012, 59:167-169.
42. Li B., Ahmed F., Bernstein P.S. Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch. Biochem. Biophys. 2010, 504:56-60.
43. Lin L., Hedayat A.S., Wu W. Statistical Tools for Measuring Agreement 2012, Springer, New York.
44. Loane E., Stack J., Beatty S., Nolan J.M. Measurement of macular pigment optical density using two different heterochromatic flicker photometers. Curr. Eye Res. 2007, 32:555-564.
45. Loughman J., Akkali M.C., Beatty S., Scanlon G., Davison P.A., O'Dwyer V., Cantwell T., Major P., Stack J., Nolan J.M. The relationship between macular pigment and visual performance. Vis. Res. 2010, 50:1249-1256.
46. Loughman J., Davison P.A., Nolan J.M., Akkali M.C., Beatty S. Macular pigment and its contribution to visual performance and experience. J.Optom. 2010, 3:74-90.
47. Loughman J., Nolan J.M., Howard A.N., Connolly E., Meagher K., Beatty S. The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol. Vis. Sci. 2012, 53:7871-7880.
48. Ludbrook J. Linear regression analysis for comparing two measurers or methods of measurement: but which regression?. Clin. Exp. Pharmacol. Physiol. 2010, 37:692-699.
49. Meagher K.A., Thurnham D.I., Beatty S., Howard A.N., Connolly E., Cummins W., Nolan J.M. Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration. Br. J. Nutr. 2012, 1-12.
50. Mellerio J., Ahmadi-Lari S., van Kuijk F.J.G.M., Pauleikhoff D., Bird A.C., Marshall J. Aportable instrument for measuring macular pigment with central fixation. Curr. Eye Res. 2002, 25:37-47.
51. Moreland J.D. Macular pigment assessment by motion photometry. Arch. Biochem. Biophys. 2004, 430:143-148.
52. Murray I.J., Makridaki M., van der Veen R.L., Carden D., Parry N.R., Berendschot T.T. Lutein supplementation over a one year period in early AMD might have a mild beneficial effect on visual acuity; the CLEAR study. Invest Ophthalmol. Vis. Sci. 2013, 54(3):1781-1788.
53. Nolan J.M., Akkali M.C., Loughman J., Howard A.N., Beatty S. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. Exp. Eye Res. 2012, 101:9-15.
54. Nolan J.M., Loughman J., Akkali M.C., Stack J., Scanlon G., Davison P., Beatty S. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vis. Res. 2011, 51:459-469.
55. Nolan J.M., Stack J., O' Donovan O., Loane E., Beatty S. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp. Eye Res. 2007, 84:61-74.
56. Nolan J.M., Stack J., O'Connell E., Beatty S. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum. Invest. Ophthalmol. Vis. Sci. 2007, 48:571-582.
57. Ossewaarde-Van N.J., van Den Biesen P.R., van De K.J., Berendschot T.T., van N.D. Comparison of fluorescence of sodium fluorescein in retinal angiography with measurements invitro. J.Biomed. Opt. 2002, 7:190-198.
58. R Development Core Team R: a Language and Environment for Statistical Computing 2009, R Foundation for Statistical Computing, Vienna.
59. Renzi L.M., Hammond B.R. The effect of macular pigment on heterochromatic luminance contrast. Exp. Eye Res. 2010, 91:896-900.
60. Resnikoff S., Pascolini D., Etya'ale D., Kocur I., Pararajasegaram R., Pokharel G.P., Mariotti S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004, 82:844-851.
61. Richer S., Devenport J., Lang J.C. LAST II: differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry 2007, 78:213-219.
62. Richer S.P., Stiles W., Graham-Hoffman K., Levin M., Ruskin D., Wrobel J., Park D.W., Thomas C. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry 2011, 82:667-680.
63. Sabour-Pickett S., Nolan J.M., Loughman J., Beatty S. Areview of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. Mol. Nutr. Food Res. 2011, 10.
64. Sasamoto Y., Gomi F., Sawa M., Tsujikawa M., Nishida K. Effect of 1-year lutein supplementation on macular pigment optical density and visual function. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249:1847-1854.
65. Snodderly D.M. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am. J. Clin. Nutr. 1995, 62:S1448-S1461.
66. Snodderly D.M., Brown P.K., Delori F.C., Auran J.D. The macular pigment .1. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest. Ophthalmol. Vis. Sci. 1984, 25:660-673.
67. Spaide R.F. Fundus autofluorescence and age-related macular degeneration. Ophthalmology 2003, 110:392-399.
68. Sparrow J.R. Lipofuscin of the retinal pigment epithelium. Atlas of Fundus Autofluorescence Imaging 2007, vol. 1:3-11. Springer, Berlin.
69. Stabell U., Stabell B. Variation in density of macular pigmentation and in short-wave cone sensitivity with eccentricity. J.Opt. Soc. Am. 1980, 70:706-711.
70. Stringham J.M., Garcia P.V., Smith P.A., McLin L.N., Foutch B.K. Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort. Invest Ophthalmol. Vis. Sci. 2011, 52:7406-7415.
71. Stringham J.M., Hammond B.R. The glare hypothesis of macular pigment function. Optom. Vis. Sci. 2007, 84:859-864.
72. Stringham J.M., Hammond B.R. Macular pigment and visual performance under glare conditions. Optom. Vis. Sci. 2008, 85:82-88.
73. Stringham J.M., Hammond B.R., Nolan J.M., Wooten B.R., Mammen A., Smollon W., Snodderly D.M. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp. Eye Res. 2008, 87:445-453.
74. Sujak A., Gabrielska J., Grudzinski W., Borc R., Mazurek P., Gruszecki W.I. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch. Biochem. Biophys. 1999, 371:301-307.
75. Tanito M., Obana A., Gohto Y., Okazaki S., Gellermann W., Ohira A. Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectrophotometry and autofluorescence imaging. Jpn. J. Ophthalmol. 2012, 56:488-496.
76. van den Berg T.J.T.P., Franssen L., Coppens J.E. Ocular media clarity and straylight. Encyclopedia of the Eye 2010, 173-183. Elsevier, Oxford. D.A. Dartt, J.C. Besharse, R. Dana (Eds.).
77. Weigert G., Kaya S., Pemp B., Sacu S., Lasta M., Werkmeister R.M., Dragostinoff N., Simader C., Garhofer G., Schmidt-Erfurth U., Schmetterer L. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2011, 52:8174-8178.
78. Wooten B.R., Hammond B.R. Macular pigment: influences on visual acuity and visibility. Prog. Retin. Eye Res. 2002, 21:225-240.
79. Wooten B.R., Hammond B.R. Spectral absorbance and spatial distribution of macular pigment using heterochromatic flicker photometry. Optom. Vis. Sci. 2005, 82:378-386.
80. Wooten B.R., Hammond B.R., Land R.I., Snodderly D.M. Apractical method for measuring macular pigment optical density. Invest. Ophthalmol. Vis. Sci. 1999, 40:2481-2489.
81. Wrona M., Rozanowska M., Sarna T. Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids. Free Radic. Biol. Med. 2004, 36:1094-1101.
82. Wustemeyer H., Jahn C., Nestler A., Barth T., Wolf S. Anew instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Archive Clin. Exp. Ophthalmol. 2002, 240:666-671.
83. Yao Y., Qiu Q.H., Wu X.W., Cai Z.Y., Xu S., Liang X.Q. Lutein supplementation improves visual performance in Chinese drivers: 1-year randomized, double-blind, placebo-controlled study. Nutrition 2013, 10.
84. Zagers N.P.A., van de Kraats J., Berendschot T.T., van Norren D. Simultaneous measurement of foveal spectral reflectance and cone-photoreceptor directionality. Appl. Opt. 2002, 41:4686-4696.